Measured Wealth Private Client Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Measured Wealth Private Client Group's MDT Position: Q2 2026 in Review
Measured Wealth Private Client Group increased its Medtronic (MDT) stake by 0.47% in Q2 2026, buying an estimated $2.42K and bringing the position to 6,430 shares worth $503K. The position accounts for 0.12% of the portfolio, ranked #116.
Measured Wealth Private Client Group first reported a position in MDT in Q3 2018 and has held it in 25 quarters since. The position peaked at $968K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Measured Wealth Private Client Group held 6,430 shares of Medtronic worth $503K as of Q2 2026.
- Measured Wealth Private Client Group bought 30 Medtronic shares in Q2 2026, an estimated $2.42K.
- Medtronic made up 0.12% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #116 holding.
- Measured Wealth Private Client Group first reported a position in Medtronic in Q3 2018 and has held it in 25 quarters since.
- Measured Wealth Private Client Group's Medtronic position peaked at $968K in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.